Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure (SafeCell Heart): A Systematic Review and Meta‐Analysis

Preclinical and clinical evidence suggests that mesenchymal stem cells (MSCs) may be beneficial in treating both acute myocardial infarction (AMI) and ischemic heart failure (IHF). However, the safety profile and efficacy of MSC therapy is not well‐known. We conducted a systematic review of clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Lalu, Manoj M., Mazzarello, Sasha, Zlepnig, Jennifer, Dong, Yuan Yi (Ryan), Montroy, Joshua, McIntyre, Lauralyn, Devereaux, P.J., Stewart, Duncan J., David Mazer, C., Barron, Carly C., McIsaac, Daniel I., Fergusson, Dean A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Human Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265630/
https://www.ncbi.nlm.nih.gov/pubmed/30255989
http://dx.doi.org/10.1002/sctm.18-0120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265630/
https://www.ncbi.nlm.nih.gov/pubmed/30255989
http://dx.doi.org/10.1002/sctm.18-0120

Ejemplares similares